Skip to content

Opus Genetics IRD Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$65.54M-297%-$16.52M+5.3%-$17.45M-135%-$7.42M+9.4%-$8.19M+76.7%
$13K0.0%$13K0.0%$13K-7.1%$14K+7.7%$13K+30.0%
$1.46M+89.1%$774K-5.1%$816K-8.9%$896K-1.9%$913K+14.8%
-$12.73M-29.4%-$9.83M-59.7%-$6.16M+40.0%-$10.27M-14.2%-$8.99M-20.9%
$0$0$0$0-100%
$0$0$0$0$0-100%
$27.6M+14.5%$24.11M+431%$4.54M+401%$906K-95.6%$20.47M
$14.87M+4.1%$14.28M$11.47M+282%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Opus Genetics generate?
Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
Where does Opus Genetics's cash flow data come from?
Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.